Concomitant Chlamydia trachomatis and human papilloma virus infection cannot be attributed solely to sexual behaviour

  • V. Verhoeven
  • M. Baay
  • J. Weyler
  • D. Avonts
  • F. Lardon
  • P. Van Royen
  • J. B. Vermorken
Brief Report


  1. 1.
    Franco EL, Duarte-Franco E, Ferenczy A (2001) Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. Can Med Assoc J 164:1017–1025Google Scholar
  2. 2.
    Castellsague X, Bosch FX, Munoz N (2002) Environmental co-factors in HPV carcinogenesis. Virus Res 89:191–199CrossRefPubMedGoogle Scholar
  3. 3.
    Smith JS, Munoz N, Herrero R et al (2002) Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis 185:324–331CrossRefPubMedGoogle Scholar
  4. 4.
    Jha PK, Beral V, Peto J et al (1993) Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk. Lancet 341:1116–1118CrossRefPubMedGoogle Scholar
  5. 5.
    Finan RR, Tamim H, Almawi WY (2002) Identification of Chlamydia trachomatis DNA in human papillomavirus (HPV) positive women with normal and abnormal cytology. Arch Gynecol Obstet 266:168–171CrossRefPubMedGoogle Scholar
  6. 6.
    Anttila T, Saikku P, Koskela P et al (2001) Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. J Am Med Assoc 285:47–51CrossRefGoogle Scholar
  7. 7.
    Wallin KL, Wiklund F, Luostarinen T et al (2002) A population-based prospective study of Chlamydia trachomatis infection and cervical cancer. Int J Cancer 101:371–374CrossRefPubMedGoogle Scholar
  8. 8.
    Munoz N, Kato I, Bosch FX et al (1996) Risk factors for HPV DNA detection in middle-aged women. Sex Transm Dis 23:504–510PubMedGoogle Scholar
  9. 9.
    Tamim H, Finan RR, Sharida HE et al (2002) Cervicovaginal coinfections with human papillomavirus and Chlamydia trachomatis. Diagn Microbiol Infect Dis 43:277–281CrossRefPubMedGoogle Scholar
  10. 10.
    Verhoeven V, Avonts D, Meheus A et al (2003) Chlamydial infection: an accurate model for opportunistic screening in general practice. Sex Transm Infect 79:313–317CrossRefPubMedGoogle Scholar
  11. 11.
    Van Dyck E, Ieven M, Pattyn S et al (2001) Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by enzyme immunoassay, culture, and three nucleic acid amplification tests. J Clin Microbiol 39:1751–1756Google Scholar
  12. 12.
    Baay MFD, Smits E, Tjalma WAA et al (2004) Can cervical cancer screening be stopped at 50: the prevalence of HPV in elderly women. Int J Cancer 108:258–261CrossRefPubMedGoogle Scholar
  13. 13.
    Sellors JW, Karwalajtys TL, Kaczorowski J et al (2003) Incidence, clearance and predictors of human papillomavirus infection in women. Can Med Assoc J 168:421–425Google Scholar
  14. 14.
    Schachter J, McCormack WM, Chernesky MA et al (2003) Vaginal swabs are appropriate specimens for diagnosis of genital tract infection with Chlamydia trachomatis. J Clin Microbiol 41:3784–3789Google Scholar
  15. 15.
    Hillemanns P, Kimmig R, Huttemann U et al (1999) Screening for cervical neoplasia by self-assessment for human papillomavirus DNA. Lancet 354:1970CrossRefPubMedGoogle Scholar
  16. 16.
    Baay M, Lardon F, Vermorken JB et al (2004) HPV in cervix and vagina. Sex Transm Infect 80:249–250CrossRefGoogle Scholar
  17. 17.
    Mavoungou E, Poaty-Mavoungou V, Toure FS et al (1999) Impairment of natural killer cell activity in Chlamydia trachomatis infected individuals. Trop Med Int Health 4:719–727CrossRefPubMedGoogle Scholar
  18. 18.
    Zhong G, Fan P, Ji H, Dong F, Huang Y (2001) Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J Exp Med 193:935–942CrossRefPubMedGoogle Scholar
  19. 19.
    Morré SA, van den Brule AJC, Rozendaal L et al (2002) The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinincal PID after one-year follow-up. Int J STD AIDS 13:12–18CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • V. Verhoeven
    • 1
  • M. Baay
    • 2
  • J. Weyler
    • 3
  • D. Avonts
    • 1
  • F. Lardon
    • 2
  • P. Van Royen
    • 1
  • J. B. Vermorken
    • 2
  1. 1.Academic Centre for General PracticeUniversity of AntwerpWilrijkBelgium
  2. 2.Department of OncologyUniversity of AntwerpWilrijkBelgium
  3. 3.Department of Epidemiology and Social MedicineUniversity of AntwerpWilrijkBelgium

Personalised recommendations